{"id":41517,"date":"2021-10-31T08:00:13","date_gmt":"2021-10-31T08:00:13","guid":{"rendered":"https:\/\/i-base.info\/htb\/?p=41517"},"modified":"2022-05-11T16:21:24","modified_gmt":"2022-05-11T16:21:24","slug":"htb-no-10-plus-hiv-and-covid-19-31-october-2021","status":"publish","type":"post","link":"https:\/\/i-base.info\/htb\/41517","title":{"rendered":"HTB: no. 10 \u2013 plus HIV and COVID-19 (31 October 2021)"},"content":{"rendered":"<ul>\n<li><a href=\"https:\/\/i-base.info\/htb\/date\/2021\/10\">Contents online<\/a><\/li>\n<li><a href=\"https:\/\/i-base.info\/htb\/wp-content\/uploads\/2021\/11\/HIV-and-COVID-19-no-10-October-2021-1-column.pdf\" rel=\"noopener\">Download October 2021<\/a>\u00a0 \u2013 1 column<\/li>\n<li><a href=\"https:\/\/i-base.info\/forms\/esub.php\">Subscribe to HTB by email<\/a><\/li>\n<\/ul>\n<p><strong><img loading=\"lazy\" decoding=\"async\" class=\"alignright wp-image-41491\" src=\"https:\/\/i-base.info\/htb\/wp-content\/uploads\/2021\/10\/logo2-300x284.png\" alt=\"\" width=\"229\" height=\"218\" srcset=\"https:\/\/i-base.info\/htb\/wp-content\/uploads\/2021\/10\/logo2-300x284.png 300w, https:\/\/i-base.info\/htb\/wp-content\/uploads\/2021\/10\/logo2.png 454w\" sizes=\"auto, (max-width: 229px) 100vw, 229px\" \/>Although this issue is published slightly later in the month than is usual, it allows us to lead with first reports from the 18th EACS hybrid conference hosted in London.<\/strong><\/p>\n<p>The conference was a great success, and EACS deserve support for developing a hybrid conference that included the option of attending either virtually or face-to-face.<\/p>\n<p>Those able to attend appreciated the first chance to connect at a large international meeting with friends and colleagues since COVID-19.<\/p>\n<p>Other HIV news includes:<\/p>\n<ul>\n<li>The approval in Scotland of the first injectable ART.<\/li>\n<li>The decision not to seek approval of F\/TAF as PrEP in the EU.<\/li>\n<li>BHIVA guidelines for HIV-2,<\/li>\n<li>Continued use in some settings of cotrimoxazole at high CD4 counts and<\/li>\n<li>The long awaited results on the clinical benefits of screening for anal cancer in people living with HIV.<\/li>\n<\/ul>\n<div>\n<p class=\"HTBBODYtext\"><span lang=\"EN-US\">Plus much more, including updates on HIV and COVID-19 and related vaccine news.<\/span><\/p>\n<\/div>\n","protected":false},"excerpt":{"rendered":"<p>First reports from EACS 2021, injectable ART in Scotland, UK guidelines for HIV-2 and more&#8230;<\/p>\n","protected":false},"author":3,"featured_media":41550,"comment_status":"open","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[5],"tags":[],"class_list":["post-41517","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-editorial"],"_links":{"self":[{"href":"https:\/\/i-base.info\/htb\/wp-json\/wp\/v2\/posts\/41517","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/i-base.info\/htb\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/i-base.info\/htb\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/i-base.info\/htb\/wp-json\/wp\/v2\/users\/3"}],"replies":[{"embeddable":true,"href":"https:\/\/i-base.info\/htb\/wp-json\/wp\/v2\/comments?post=41517"}],"version-history":[{"count":0,"href":"https:\/\/i-base.info\/htb\/wp-json\/wp\/v2\/posts\/41517\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/i-base.info\/htb\/wp-json\/wp\/v2\/media\/41550"}],"wp:attachment":[{"href":"https:\/\/i-base.info\/htb\/wp-json\/wp\/v2\/media?parent=41517"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/i-base.info\/htb\/wp-json\/wp\/v2\/categories?post=41517"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/i-base.info\/htb\/wp-json\/wp\/v2\/tags?post=41517"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}